These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 17515110

  • 1. [Mucosal immunotherapy for alzheimer's disease with viral vectors].
    Hara H, Inoue M, Adachi K, Yonemitsu Y, Hasegawa M, Nabeshima T, Tabira T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Apr; 27(2):53-6. PubMed ID: 17515110
    [Abstract] [Full Text] [Related]

  • 2. [Abeta vaccine therapy for Alzheimer's disease].
    Hara H.
    Rinsho Shinkeigaku; 2005 Nov; 45(11):867-9. PubMed ID: 16447748
    [Abstract] [Full Text] [Related]

  • 3. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
    Vasilevko V, Cribbs DH.
    Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
    [Abstract] [Full Text] [Related]

  • 4. Mucosal immunotherapy in an Alzheimer mouse model by recombinant Sendai virus vector carrying Aβ1-43/IL-10 cDNA.
    Hara H, Mouri A, Yonemitsu Y, Nabeshima T, Tabira T.
    Vaccine; 2011 Oct 06; 29(43):7474-82. PubMed ID: 21803105
    [Abstract] [Full Text] [Related]

  • 5. [Perspectives in immunotherapy of Alzheimer's disease].
    Rossi G.
    Recenti Prog Med; 2003 Oct 06; 94(7-8):305-8. PubMed ID: 12868235
    [Abstract] [Full Text] [Related]

  • 6. [Vaccination therapy for Alzheimer's disease].
    Tabira T.
    Brain Nerve; 2007 Apr 06; 59(4):375-82. PubMed ID: 17447524
    [Abstract] [Full Text] [Related]

  • 7. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
    Rakover I, Arbel M, Solomon B.
    Neurodegener Dis; 2007 Apr 06; 4(5):392-402. PubMed ID: 17536186
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of Alzheimer disease: A beta vaccine].
    Tabira T, Hara H.
    Rinsho Shinkeigaku; 2004 Nov 06; 44(11):778-80. PubMed ID: 15651289
    [Abstract] [Full Text] [Related]

  • 15. Modulation of microglial activation state following passive immunization in amyloid depositing transgenic mice.
    Morgan D.
    Neurochem Int; 2006 Jul 06; 49(2):190-4. PubMed ID: 16740342
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Abeta1-6: toward safer and effective vaccines against Alzheimer's disease.
    Kim HD, Maxwell JA, Kong FK, Tang DC, Fukuchi K.
    Biochem Biophys Res Commun; 2005 Oct 14; 336(1):84-92. PubMed ID: 16126169
    [Abstract] [Full Text] [Related]

  • 20. Immunotherapy as treatment for Alzheimer's disease.
    Hawkes CA, McLaurin J.
    Expert Rev Neurother; 2007 Nov 14; 7(11):1535-48. PubMed ID: 17997702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.